Released Mar 2, 2017, after the close
10-K filed Mar 3, 2017, 62 days after period end · 0001628280-17-002137
Q4 2016 · 10-K
Revenue$25.08M$25.08M −18.4% vs Q4 2015+13.0% vs Q3 2016
Net Income-$17.70M-$17.70M derivedN/M vs Q4 2015N/M vs Q3 2016
EPS Diluted-$0.61-$0.61 N/M vs Q4 2015N/M vs Q3 2016
Operating Incomederived-$17,696,000N/M
Operating Cash Flowderived-$10,730,000N/M
Free Cash Flowderived-$11,424,000N/M
Margins · derived
Operating margin-70.5%−26.0 pt vs Q4 2015
Net margin-70.5%−28.6 pt vs Q4 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $25.08M | $30.72M | $33.49M | $20.88M |
| Net Income | -$17.70M | -$12.88M | -$10.94M | -$4.64M |
| EPS Diluted | -$0.61 | -$0.45 | -$0.39 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR